Notice of Intent to Sole Source for the Bio-techne Ella cartridges kits and consumables.
ID: HT942524RG0829Type: Special Notice
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)ARMY MED RES ACQ ACTIVITYFORT DETRICK, MD, 21702, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Original Source

https://sam.gov/opp/920e4231400d4705b223e8154891ade3/view
Timeline
    Description

    The Department of Defense, through the Army Medical Research Acquisition Activity, intends to award a sole-source contract to Bio-Techne Sales Corporation for the procurement of Bio-techne Ella cartridges kits and consumables. This acquisition aims to secure reagent kits compatible with the Biotechne Ella analyzer, which are essential for the U.S. Army Research Institute of Environmental Medicine's operations. The total estimated value of the contract is $4,200,000, and interested parties are invited to submit capability statements to Roberto Gonzalez by 10:00 A.M. EST on September 12, 2022, as no competitive proposals will be solicited.

    Files
    No associated files provided.
    Similar Opportunities
    Chemistry Molecular Cost Per Reportable Results
    Active
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is seeking proposals for Chemistry/Immunoassay Analyzers, Reagents, and related services at the Dwight D. Eisenhower Army Medical Center located in Fort Gordon, Georgia. The procurement aims to support military healthcare operations by providing essential medical diagnostic equipment and reagents, particularly for laboratory tests focused on sexually transmitted infections, including Chlamydia trachomatis, Neisseria gonorrhea, and Human Papilloma Virus (HPV). This contract, expected to be awarded as a Firm Fixed Price agreement, includes installation, training, and ongoing maintenance, with proposals due by September 20, 2024. Interested vendors should direct inquiries to Jacquetta White at jacquetta.o.white.civ@health.mil or Sebrena L. Lane at sebrena.l.hackleylane.civ@health.mil for further details.
    CHEMISTRY AND IMMUNOASSAY TESTING PROGRAM
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE is planning to issue a sole source award contract to Roche Diagnostics Corporation for the Chemistry and Immunoassay Testing Program. This program is intended to sustain the use of three Chemistry and Immunochemistry Systems under a Cost Per Reportable Result (CPRR) agreement or Cost Per Reagent Pack. The program includes equipment, reagents, tools, materials, training, and a water purification system, Uninterruptible Power Supply (UPS), and services necessary to meet the Chemistry and Immunochemistry testing and analysis requirements for Walter Reed National Military Medical Center (WRNMMC) laboratories. The anticipated period of performance is five years.
    Thermo Scientific Microtome Maintenance
    Active
    Dept Of Defense
    The Department of Defense, specifically the U.S. Army Health Contracting Activity, is seeking qualified businesses to provide maintenance services for Thermo Scientific microtomes and tissue processors at the William Beaumont Army Medical Center in Fort Bliss, Texas. The procurement includes both scheduled preventive maintenance and unscheduled repairs, with a requirement for technicians to be OEM-certified and trained within the last 24 months. This maintenance is critical for ensuring the operational readiness of laboratory equipment used in medical readiness activities. Interested parties must submit their capability statements and relevant business information to Contract Specialist Robert Knight at robert.h.knight.civ@health.mil by 1:00 p.m. Mountain Time on September 18, 2024, as this is a Sources Sought Notice and not a formal solicitation.
    Hematology Analyzer (Sole Source)
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) intends to award a sole source contract to Sysmex America, Inc. for the provision of one XN550 Hematology Analyzer, along with necessary service and consumables, for use at Edwards Air Force Base in California. This procurement is essential for maintaining the operational capabilities of the military's healthcare services, as the XN550 is a critical tool for hematological testing, and Sysmex is the only vendor capable of supplying compatible testing supplies. The contract will span five years, consisting of one base year and four optional years, with delivery expected to commence on October 1, 2025. Interested vendors may submit capability statements by September 17, 2024, to contest the sole source designation; however, this notice does not constitute a solicitation for competitive bids. For further inquiries, contact Brandi Roberts at brandi.m.roberts5.civ@health.mil or (726) 203-0162, or Mariangela Monsalve at mariangela.j.monsalve.civ@mail.mil or (726) 203-0120.
    J065--Bioplex Maintenance Agreement Intent to Sole Source For Louis Stokes Cleveland Medical Center
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 10, intends to negotiate a sole source Firm-Fixed Price Contract for a maintenance agreement concerning the Bio-Rad Laboratories Bioplex system at the Louis Stokes Cleveland Medical Center. This procurement is essential for ensuring the operational integrity and reliability of the Bioplex system, which is critical for medical diagnostics and patient care. The government has determined that Bio-Rad Laboratories is the only source capable of fulfilling this requirement, and while this is a non-competitive notice, interested contractors may submit capabilities statements by the deadline of September 17, 2024, to Sara Wood, Contract Specialist, at sara.wood1@va.gov. No solicitation package will be available, and responses must demonstrate clear evidence that competition would be advantageous to the government.
    Notice of Intent to Sole-Source - Hematology Analyzer Services
    Active
    Dept Of Defense
    The Department of Defense, specifically the 341st Contracting Squadron at Malmstrom Air Force Base in Montana, intends to award a sole-source contract to Sysmex America, Inc. for routine preventative maintenance services and reagents for the Sysmex Hematology Analyzer Unit. This procurement is critical as the analyzer requires specific reagents that are exclusively provided by Sysmex America, making them the only viable source for fulfilling this requirement. Interested parties may submit a capability statement or proposal demonstrating why competitive bidding would be advantageous, with submissions due by 14 October 2024 at 2:00 PM MST. For further inquiries, contact SSgt Kevin Luccitti at kevin.luccitti@us.af.mil or SSgt Joshua Crist at joshua.crist.1@us.af.mil.
    BIOMERIEUX REAGENTS AND BLOOD CULTURE BOTTLES
    Active
    Dept Of Defense
    The Department of Defense, specifically the U.S. Navy, is seeking suppliers for laboratory reagents and blood culture bottles necessary for blood testing at the U.S. Navy Hospital in Naples, Italy. The procurement aims to acquire consumable supplies compatible with the Government-owned VITEK@2 Compact and BacT/ALERT@ 3D equipment utilized by the laboratory department. These supplies are critical for ensuring accurate and timely blood testing, which is essential for patient care and medical diagnostics. Interested vendors can reach out to Luca Buonocunto at the provided email or telephone number for further details regarding the solicitation process.
    Laboratory Supplies and Wares - ECAT
    Active
    Dept Of Defense
    Presolicitation notice: Laboratory Supplies and Wares - ECAT The Department of Defense is seeking laboratory supplies and wares for various medical laboratories worldwide, including locations inside and outside the Continental United States (CONUS). These supplies are used by U.S. soldiers, sailors, airmen, and marines for research, diagnostics, and testing purposes. The solicitation aims to establish long-term contracts for the purchase of laboratory supplies through the DLA Electronic Catalog (ECAT). The estimated value of the contracts over a five-year period is $491,800,000.00, with a maximum value of $983,600,000.00. Interested parties can submit proposals at any time during the open periods of the solicitation. The Berry Amendment and the Trade Agreements Act apply to the laboratory items covered under this acquisition. For more information, contact Marie Crescenzo, the Contracting Officer, at marie.crescenzo@dla.mil. All responsible sources are encouraged to submit proposals.
    Leica Equipment Maintenance
    Active
    Dept Of Defense
    The Department of Defense, specifically the U.S. Army Health Contracting Activity, is seeking qualified businesses to provide maintenance services for various Leica medical equipment at the William Beaumont Army Medical Center (WBAMC) in Fort Bliss, Texas. The procurement includes both scheduled preventive maintenance and unscheduled repairs for equipment such as the Leica ASP6025 Automated Vacuum Tissue Processor and several stainers and embedding systems, all requiring technicians with OEM-specific training and certifications. This maintenance is crucial for ensuring the operational readiness and reliability of medical equipment used in patient care. Interested parties must submit their capability statements and relevant business information to Contract Specialist Robert Knight via email by 1:00 p.m. Mountain Time on September 18, 2024, as this notice serves as a market research tool and not a formal solicitation.
    Notice of Intent - Ortho Clinical Reagents and Supplies
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to award a fixed-price contract for Ortho Clinical reagents and supplies, specifically for the Department of Transfusion Medicine at the NIH Clinical Center in Bethesda, Maryland. This procurement aims to secure essential analyzer supplies and reagents that are critical for ensuring the safety and effectiveness of blood products used in transfusion therapy, which must meet specific compatibility requirements for patient treatment. The selected supplier, Ortho-Clinical Diagnostics, Inc., is the sole source for these unique reagents, which have undergone extensive validation studies and are necessary for compatibility testing of both patients and blood donors. Interested parties capable of providing similar products may submit a capability statement by September 22, 2024, to Sheri Eiri at sheri.eiri@nih.gov, as the contract is contingent upon the availability of FY2025 funding.